Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Posarelli

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Rheumatology|May 14, 2013
Ocular involvement in giant cell arteritisM Figus, R Talarico, C Posarelli, et al.
Journal of Endocrinological Investigation|December 21, 2023
IgG4 serum levels in Graves' orbitopathyS Comi, G Lanzolla, G Cosentino, et al.
Journal of Endocrinological Investigation|July 13, 2022
Sirolimus as a second-line treatment for Graves' orbitopathyG Lanzolla, M N Maglionico, S Comi, et al.
Journal of Endocrinological Investigation|January 25, 2023
Absence of a relationship between vitamin D and Graves' orbitopathyG Lanzolla, L Di Matteo, S Comi, et al.
Journal of Endocrinological Investigation|August 27, 2022
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathyG Lanzolla, L Puccinelli, M Giudetti, et al.
Journal of Endocrinological Investigation|July 11, 2020
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathyF Nicolì, G Lanzolla, M Mantuano, et al.
Journal of Endocrinological Investigation|October 21, 2021
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort studyG Rotondo Dottore, L Torregrossa, G Lanzolla, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Rheumatology|May 14, 2013
Ocular involvement in giant cell arteritisM Figus, R Talarico, C Posarelli, et al.
Journal of Endocrinological Investigation|December 21, 2023
IgG4 serum levels in Graves' orbitopathyS Comi, G Lanzolla, G Cosentino, et al.
Journal of Endocrinological Investigation|July 13, 2022
Sirolimus as a second-line treatment for Graves' orbitopathyG Lanzolla, M N Maglionico, S Comi, et al.
Journal of Endocrinological Investigation|January 25, 2023
Absence of a relationship between vitamin D and Graves' orbitopathyG Lanzolla, L Di Matteo, S Comi, et al.
Journal of Endocrinological Investigation|August 27, 2022
Anti-nuclear autoantibodies in Graves' disease and Graves' orbitopathyG Lanzolla, L Puccinelli, M Giudetti, et al.
Journal of Endocrinological Investigation|July 11, 2020
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathyF Nicolì, G Lanzolla, M Mantuano, et al.
Journal of Endocrinological Investigation|October 21, 2021
Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort studyG Rotondo Dottore, L Torregrossa, G Lanzolla, et al.
Pageof 1